| Pharmaceutical active ingredients: |
| Quinidine Polygalacturonate |
| Available forms, composition and doses of Cardioquin: |
| Tablets; Oral; Quinidine Polygalacturonate 275 mg |
| Cardioquin medical category: |
| Human:Cardiac drugsClass IA antiarrythmics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01BA01 - Quinidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Purdue Pharma |
| Related documents and information about Cardioquin: |
| Cardioquin prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Natcardine | Quinidine Phenylethylbarbiturate | Franco-Indian Pharmaceuticals |
| Natisedina | Quinidine Phenylethylbarbiturate | Teofarma; Almirall |
| Natisedine | Quinidine Phenylethylbarbiturate | Sanofi-Aventis; Barrenne Industria Farmaceutica; Sabex; Solvay |
| Prosedyl | Quinidine Phenylethylbarbiturate | Rougier Pharma |
| Quinobarb | Quinidine Phenylethylbarbiturate | Rougier Pharma |
| Cardioquine | Quinidine Polygalacturonate | Viatris; Almirall |
| Galactoquin | Quinidine Polygalacturonate | Mundipharma |
| Naticardina | Quinidine Polygalacturonate | Viatris |
| Neochinidin | Quinidine Polygalacturonate | Stabilimento Chimico Farmaceutico Dr. L. Brocchieri |
| Ritmocor | Quinidine Polygalacturonate | Malesci Istituto Farmacobiologico |